
#1964 - Rick Doblin
Rick Doblin, Ph.D., is the Founder in 1986 and President of the Multidisciplinary Association for Psychedelic Studies (MAPS), a nonprofit that wholly owns its pharmaceutical arm, MAPS Public Benefit Corporation (PBC), which has completed two highly successful Phase 3 studies of MDMA-assisted therapy for PTSD. MAPS PBC stands at a crossroads between obtaining the additional resources it needs from philanthropy, ensuring public benefit is foremost, or becoming a publicly traded company.
maps.org
Episodes with Rick Doblin
Related Episodes
Categories
Key Takeaways
Psychedelics can play a vital role in healing veterans' PTSD.
This insight emphasizes the therapeutic potential of psychedelics for mental health.
Civil disobedience is framed as a form of patriotism.
This perspective encourages questioning governmental actions and morality in society.
Psychedelics can help people confront and abandon preconceived notions.
This insight highlights the transformative potential of psychedelics in personal development.
The neuroplasticity of the brain allows for new connections and healing.
Understanding neuroplasticity is crucial for recognizing how psychedelics might aid in trauma recovery.
Psychedelics can promote lasting neuroplastic changes in the brain.
This is vital for understanding new therapeutic avenues for mental health.
Episode Timestamps
Exploring Psychedelics and Civil Disobedience in American Culture
- Discussion centers on the role of psychedelics in modern society and culture.
- Conversations about civil disobedience and patriotism highlight personal beliefs and history.
- Notable figures, like Dave Chappelle and Daniel Ellsberg, are referenced in the context.
Exploring the Transformative Power of Psychedelics
- Psychedelics can profoundly alter perceptions of life and consciousness.
- Experiences with DMT and Ibogaine reveal insights into human existence.
- Psychedelic research shows potential benefits for mental health and addiction treatment.
Exploring Psychedelics: Neuroplasticity and Therapeutic Potential
- Research shows psychedelics like Ibogaine enhance neuroplasticity and emotional healing.
- Historical figures like Leo Zeff contributed significantly to MDMA's therapeutic uses.
- Current opiate crisis highlights the need for effective psychedelic remedies.
Exploring Psychedelics for Healing and Drug Policy Reform
- Psychedelic experiences can help sever connections between self-criticism and self-hatred.
- Ibogaine is proposed as a treatment for drug addiction amidst the opioid crisis.
- Drug policy reform discussions focus on moving psychedelics toward legal medical use.
Debating Drug Policies and Their Societal Impact
- Discussion on the misconceptions surrounding drug use and its implications.
- Importance of changing perceptions on psychedelics for societal healing.
- Personal anecdotes highlight the need for compassion in drug policy reform.
Exploring the Therapeutic Potential of MDMA and Psychedelics
- MDMA's therapeutic potential is often misrepresented in media narratives.
- The upcoming Psychedelic Science Conference aims to educate about psychedelics.
- Addressing multi-generational trauma is crucial for mental health recovery.
Psychedelic Science Conference Highlights and Drug Policy Reform
- Psychedelic Science Conference in Denver aims to educate on psychedelics and therapy.
- Key speakers include Deepak Chopra and Aaron Rodgers discussing psychedelics' benefits.
- Denver's progressive drug policies serve as a model for psychedelic decriminalization.
Exploring MDMA's Potential in Treating PTSD Through Innovative Funding
- MAPS has raised $145 million for MDMA research, indicating strong public interest.
- Phase three studies show significant efficacy of MDMA therapy for PTSD patients.
- New public benefit corporations challenge traditional profit-maximizing models in pharma.
Exploration of MDMA, 5-HTP, and Neurotoxicity Research
- MDMA's therapeutic potential is contrasted with concerns about neurotoxicity.
- 5-HTP supplementation may help mitigate mood dips post-MDMA experience.
- Historical research errors influenced public perception and regulatory stances on MDMA.
Psychedelics and Their Impact on Spirituality and Society
- Discussion on the intersection of psychedelics and public education in Florida.
- Exploration of historical psychedelic experiments and their implications for spirituality.
- The relationship between mystical experiences and social activism is critically examined.
Debate on Marijuana Risks and Psychedelic Treatments
- Discussion on the exaggeration of marijuana benefits and minimization of risks.
- Concerns raised regarding vulnerable individuals and potential mental health impacts.
- Exploration of the potential FDA approval for psychedelics and their therapeutic use.
Exploring Cannabis Perception and Historical Propaganda Effects
- Personal experiences with cannabis edibles reveal unexpected panic reactions.
- Historical propaganda has shaped negative perceptions of cannabis over generations.
- Education about drugs is essential for informed decision-making among youth today.
Exploring the Impact of Drug Prohibition and Psychedelic Research
- Illegal drug prohibitions often lead to negative societal consequences and crime.
- The Concord Prison Experiment aimed to study psilocybin's effects on recidivism.
- Historical drug policies have roots in racial and social discrimination.
Psychedelics and Recidivism: A Complex Relationship
- The effectiveness of psychedelics in reducing recidivism is questioned.
- Support systems post-incarceration are crucial for successful reintegration.
- Current research on MDMA and veterans highlights potential benefits of psychedelics.
Discussion on MAPS Public Benefit Corp and Psychedelic Medicine
- MAPS aims for FDA approval of MDMA, potentially by June 2024.
- Concerns arise about mixing commerce with sacred substances in therapeutic contexts.
- Exploration of becoming a publicly traded company while maintaining nonprofit goals.
Exploring MDMA's Potential for PTSD and Cluster Headaches
- MDMA and psychedelics show promise in alleviating cluster headaches.
- Legal and patent challenges impact psychedelic research and treatment availability.
- Data exclusivity laws create hurdles for developing generic MDMA treatments.
FDA Approves MDMA Therapy for PTSD: A Breakthrough in Treatment
- FDA is likely to approve MDMA therapy for PTSD based on positive trial results.
- Double-blind studies confirm low-dose MDMA's effectiveness in therapeutic settings.
- Political support is growing for psychedelic therapies, indicating a cultural shift.
Discussion on the Intersection of Psychedelics and Philanthropy
- Paul Allen's $25 billion donation sparks debate on intelligence research funding.
- Parents share unconventional approaches to discussing drug use with their children.
- Concerns about drug safety and societal implications of psychedelics are highlighted.
People Mentioned
Joe Rogan
Podcaster, Comedian
Dave Chappelle
Comedian, Actor
Daniel Ellsberg
Whistleblower, Activist
Stephen Breyer
Supreme Court Justice
Rick Perry
Former Governor of Texas
Aubrey Marcus
Entrepreneur, Psychedelic Researcher
Michael Marcus
Researcher, Psychedelic Advocate
Stanislav Groff
Psychiatrist, LSD Researcher
Leo Zeff
Psychotherapist, Psychedelic advocate
Sasha Shulgin
Chemist, Psychedelic researcher
John Ehrlichman
Domestic Policy Advisor
Dr. Carl Hart
Neuroscientist, Drug Policy Reformer
Oprah Winfrey
Media Personality
Rachel Yehuda
Researcher
Sarco Garian
Police Officer, Psychotherapist
Deepak Chopra
Author, Speaker
Aaron Rodgers
NFL Player
Michael Pollan
Author, Journalist
Paul Stamets
Mycologist, Author
Ryan Zuer
Organized lead investor for MAPS
Una McCann
Researcher
George Riccardi
Researcher
Howard Thurman
Minister, civil rights leader
Bill W.
Co-founder of Alcoholics Anonymous
Timothy Leary
Psychologist, Writer, Psychologist, Researcher, Psychologist, advocate for psychedelics
Alex Berenson
Author, Journalist
Dr. Mike Hart
Cannabis Doctor
Bill Hicks
Comedian
Larry Ralph Metzner
Researcher
Jeff George
Chair of MAPS Public Benefit Corp, Former CEO of Sandos
Cummington Berling
Advocate for psychedelic therapy
Bob Temple
FDA Official
Paul Allen
Philanthropist, Co-founder of Microsoft
Rick Doblin
Founder of MAPS
Places Mentioned
Mexico
Country where Ibogaine treatment is available.
Bohemian Grove
Cultural site
Burning Man
Cultural Event
Iceland
Country
Denver Convention Center
Event Venue
Johns Hopkins
Research Institution
Research Triangle Institute
Research Institution
New College of Florida
Educational Institution
Baylor College of Medicine
Educational Institution
Books Mentioned
The Doors of Perception
Aldous Huxley
Tell Your Children
Alex Berenson
How to Change Your Mind
Michael Pollan
Change Your Mind
Michael Pollan
Notable Quotes
"person thinks law unjust violates willing suffer consequences example others unjust nature law actually highest respect law."
Discussing the moral implications of civil disobedience.
"think psychedelic experience one greatest ways someone relax ideological dogmatic ideas might restrict taking opinions left."
Talking about how psychedelics can open minds to different perspectives.
"Every time I've done it, completely made me rethink interface people, life experience."
Discussing the impact of DMT experiences on personal perception.
"Ibogaine, go couple days lot psychological experiences might want run away problems opiates."
Talking about the effects of Ibogaine on addiction.
"Ibogaine opens period neuroplasticity several weeks after, experience last day two."
Discussing the effects of Ibogaine on the brain.